{Reference Type}: Journal Article
{Title}: Targeting the PINK1/Parkin pathway: A new perspective in the prevention and therapy of diabetic retinopathy.
{Author}: D'Amico AG;Maugeri G;Magrì B;Bucolo C;D'Agata V;
{Journal}: Exp Eye Res
{Volume}: 247
{Issue}: 0
{Year}: 2024 Aug 6
{Factor}: 3.77
{DOI}: 10.1016/j.exer.2024.110024
{Abstract}: Diabetic retinopathy (DR) is a microvascular complication of diabetes characterized by neurovascular impairment of the retina. The dysregulation of the mitophagy process occurs before apoptotic cell death and the appearance of vascular damage. In particular, mitochondrial alterations happen during DR development, supporting the hypothesis that mitophagy is negatively correlated to disease progression. This process is mainly regulated by the PTEN-induced putative kinase protein 1 (PINK1)/Parkin pathway whose activation promotes mitophagy. In this review, we will summarize the evidence reported in the literature demonstrating the involvement of the PINK1/Parkin pathway in diabetic retinopathy-induced retinal degeneration.